Rg6, a rare ginsenoside, inhibits systemic inflammation through the induction of interleukin-10 and microRNA-146a
Autor: | Seungwha Paik, Jin Ho Choe, Jin-Man Kim, Gyu Yong Song, Eun-Kyeong Jo, Ga-Eun Choi, Jieun Kim |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2019 |
Předmět: |
0301 basic medicine
Lipopolysaccharides Necrosis Lipopolysaccharide Ginsenosides lcsh:Medicine Inflammation Systemic inflammation Article Sepsis 03 medical and health sciences chemistry.chemical_compound Mice 0302 clinical medicine medicine Animals lcsh:Science Multidisciplinary Chemistry Macrophages lcsh:R Interleukin medicine.disease Interleukin-10 Survival Rate Interleukin 10 MicroRNAs 030104 developmental biology Cancer research Tumor necrosis factor alpha lcsh:Q medicine.symptom 030217 neurology & neurosurgery |
Zdroj: | Scientific Reports Scientific Reports, Vol 9, Iss 1, Pp 1-15 (2019) |
ISSN: | 2045-2322 |
Popis: | The immunobiological functions of Rg6, a rare ginsenoside from ginseng, have been largely unreported. In this paper, we demonstrate that Rg6 has a significant immunosuppressive function on Toll-like receptor (TLR) 4-induced systemic inflammatory responses. Rg6 was found to negatively regulate pro-inflammatory responses and severity in vivo, and thus induced recovery in mice with lipopolysaccharide (LPS)-induced septic shock and cecal ligation and puncture (CLP)-induced sepsis. Rg6 treatment also facilitated recovery in mice with LPS-induced lung damage via reduced neutrophil infiltration and tumor necrosis factor-α expression in lung tissues. Rg6 injection also downregulated pro-inflammatory cytokines and increased the levels of interleukin (IL)-10 in the serum of septic mice. Mechanistically, Rg6 did not induce TLR negative regulators, such as A20 and IRAK-M, in bone marrow-derived macrophages (BMDMs). Instead, addition of Rg6 to LPS-activated BMDMs augmented IL-10 expression, whereas it inhibited inflammatory signaling, such as by nuclear factor κB activation and mitogen-activated protein kinases. Furthermore, Rg6 significantly induced miR-146a, an operator miRNA for anti-inflammation, in BMDMs. Collectively, these data indicate that Rg6 inhibits inflammatory responses through the induction of IL-10 and miR-146a. |
Databáze: | OpenAIRE |
Externí odkaz: |